| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |